TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 192 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2021. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $16,606,000 | +646.3% | 220,676 | +166.3% | 0.26% | +611.1% |
| Q1 2022 | $2,225,000 | -53.7% | 82,856 | -17.7% | 0.04% | -47.8% |
| Q4 2021 | $4,801,000 | +43.9% | 100,644 | +100.4% | 0.07% | +27.8% |
| Q3 2021 | $3,337,000 | -9.0% | 50,228 | +6.9% | 0.05% | -20.6% |
| Q2 2021 | $3,667,000 | -16.1% | 47,000 | +1.7% | 0.07% | -29.9% |
| Q1 2021 | $4,370,000 | -64.8% | 46,200 | -76.8% | 0.10% | -80.9% |
| Q4 2019 | $12,419,000 | – | 199,378 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 708,233 | $44,116,000 | 18.91% |
| Corriente Advisors, LLC | 285,000 | $17,753,000 | 9.54% |
| Cormorant Asset Management, LP | 3,396,650 | $211,577,000 | 8.44% |
| Opaleye Management Inc. | 340,500 | $21,210,000 | 4.16% |
| Orbimed Advisors | 2,745,327 | $171,006,000 | 2.44% |
| Parkman Healthcare Partners LLC | 101,434 | $6,318,000 | 1.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,179,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 366,000 | $22,798,000 | 0.73% |
| Artal Group S.A. | 300,000 | $18,687,000 | 0.72% |
| DAFNA Capital Management LLC | 30,408 | $1,894,000 | 0.65% |